Annual ROE
-48.93%
-12.81%-35.47%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual return on equity is -48.93%, with the most recent change of -12.81% (-35.47%) on December 31, 2023.
- During the last 3 years, ACHL annual ROE has fallen by -31.40% (-179.12%).
- ACHL annual ROE is now -254.57% below its all-time high of -13.80%, reached on December 31, 2019.
Performance
ACHL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-54.45%
-7.21%-15.26%
September 1, 2024
Summary
- As of February 7, 2025, ACHL quarterly return on equity is -54.45%, with the most recent change of -7.21% (-15.26%) on September 1, 2024.
- Over the past year, ACHL quarterly ROE has dropped by -11.90% (-27.97%).
- ACHL quarterly ROE is now -210.61% below its all-time high of -17.53%, reached on December 31, 2020.
Performance
ACHL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ACHL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.5% | -28.0% |
| 3 y3 years | -179.1% | -106.3% |
| 5 y5 years | -254.6% | -106.3% |
ACHL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -131.9% | at low | -149.4% | at low |
| 5 y | 5-year | -254.6% | at low | -210.6% | at low |
| alltime | all time | -254.6% | at low | -210.6% | at low |
Achilles Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -54.45%(+15.3%) |
| Jun 2024 | - | -47.24%(+10.0%) |
| Mar 2024 | - | -42.95%(+0.9%) |
| Dec 2023 | -48.93%(+35.5%) | -42.55%(+0.5%) |
| Sep 2023 | - | -42.33%(+13.3%) |
| Jun 2023 | - | -37.37%(+6.9%) |
| Mar 2023 | - | -34.95%(+10.2%) |
| Dec 2022 | -36.12% | -31.71%(+20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -26.40%(+9.5%) |
| Jun 2022 | - | -24.10%(+10.4%) |
| Mar 2022 | - | -21.83%(-2.0%) |
| Dec 2021 | -21.10%(+20.4%) | -22.27%(-0.4%) |
| Sep 2021 | - | -22.37%(+1.1%) |
| Jun 2021 | - | -22.12%(-2.4%) |
| Mar 2021 | - | -22.66%(+29.3%) |
| Dec 2020 | -17.53%(+27.0%) | -17.53% |
| Dec 2019 | -13.80% | - |
FAQ
- What is Achilles Therapeutics annual return on equity?
- What is the all time high annual ROE for Achilles Therapeutics?
- What is Achilles Therapeutics annual ROE year-on-year change?
- What is Achilles Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Achilles Therapeutics?
- What is Achilles Therapeutics quarterly ROE year-on-year change?
What is Achilles Therapeutics annual return on equity?
The current annual ROE of ACHL is -48.93%
What is the all time high annual ROE for Achilles Therapeutics?
Achilles Therapeutics all-time high annual return on equity is -13.80%
What is Achilles Therapeutics annual ROE year-on-year change?
Over the past year, ACHL annual return on equity has changed by -12.81% (-35.47%)
What is Achilles Therapeutics quarterly return on equity?
The current quarterly ROE of ACHL is -54.45%
What is the all time high quarterly ROE for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly return on equity is -17.53%
What is Achilles Therapeutics quarterly ROE year-on-year change?
Over the past year, ACHL quarterly return on equity has changed by -11.90% (-27.97%)